Drug regulation and approval - A to Z

Drug regulation and approval is a sub-category of Policy

• Our policy on cancer drugs

• Our policy on improving the NICE process

• News story: Some health trusts 'banning costly cancer drugs', says investigation
  24 November 2011
• News story: Prostate cancer drug abiraterone launched in UK
  21 September 2011
• News story: New £50m fund to improve drug access for cancer patients
  1 October 2010
• News story: NICE draft guidance rejects bevacizumab for advanced bowel cancer
  24 August 2010
• News story: £50m interim fund to improve access to cancer drugs
  27 July 2010
• News story: People with rarer cancers 'still denied access to treatments'
  17 March 2010
• News story: NICE agrees cost-reducing scheme for new cancer drug trabectedin
  22 December 2009
• News story: NICE recommends topotecan for cervical cancer
  29 October 2009
• News story: NICE approves lenalidomide for multiple myeloma patients who have received previous treatments
  24 June 2009
• News story: NHS in Wales to fund four kidney cancer drugs pending NICE approval
  23 January 2009

• News story: Advanced skin cancer drug 'not cost-effective' for NHS
  14 October 2011
• News story: NICE recommends azacitidine for myelodysplastic syndromes
  24 March 2011
• News story: NICE recommends bortezomib and thalidomide for multiple myeloma
  26 August 2010
• News story: Report shows cost-sharing money not getting through
  29 July 2010
• News story: NICE rejects lapatinib for advanced breast cancer
  10 June 2010
• News story: NICE rejects drug for rare pre-cancerous conditions
  5 March 2010
• News story: NICE rules against liver cancer drug sorafenib
  19 November 2009
• News story: NICE rejects life-extending breast cancer drug lapatinib
  23 October 2009
• News story: Kidney cancer drug gets NHS approval
  4 February 2009
• News story: Report looks at access to cancer drugs in Europe
  22 January 2009

• September 2008 podcast

• May 2008 podcast